Hello, Fool! | Login | Signup | My Fool
Dec 3, 2008 10:36 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company focuses on the development and commercialization of new therapeutics for the treatment of short stature and other endocrine disorders.
View All Commentary (TRCA)
Recs
theonlyslacker (25.18) Submitted: 4/26/07 7:39 AM : Start Price: $6.74 TRCA Score: -74.67
This stock has had a solid run up with little to no news.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK